Barco secures US-FDA product variance for its first-in-the-world, commercial laser-illuminated cinema projector, assuring hassle- and worry-free installation
April 15, 2014
Kortrijk, Belgium, 15 April 2014 – Barco, a global digital cinema leader, is pleased to announce that the US Food and Drug Administration (FDA) has granted a product variance for its brand-new 6 primary laser 3D (6P) laser-illuminated projector. The FDA has also granted approval for a predefined laser show variance, allowing US-based exhibitors to safely install the 4K Barco laser projector without excessive legal constraints and extra costs. In this way, exhibitors who install the Barco laser projector do not need to prove compliancy with the same stringent regulations as laser light shows. Thanks to its fully integrated and inherently safe design – featuring unified laser light sources that are housed within the projector – the Barco laser projector prevents direct contact with native laser light, offering exhibitors worry-free operation and ultimate peace of mind.